Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Latest filing published 12 Mar 2026 for Ironwood Pharmaceuticals INC.
Filing timeline
BuySaleMichael Shetzline
Insider track record
Disclosed buys
0
Disclosed sells
21
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael Shetzline: trading record in brief
All filings by Michael Shetzline on record concern Ironwood Pharmaceuticals Inc, in the capacity of senior executive. Over a trading history stretching from 24 April 2020 to 10 March 2026, the count stands at 34 filings.
Sales make up the whole of the open-market record (21 sales, €1.6M). The rest of the record consists of 12 share grants and 1 option exercise. Since January 2026: no purchases and 2 sales on the market.
The record was last updated on 12 March 2026 with a share grant in Ironwood Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael Shetzline
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
136,612 shares0Class A Common StockSEC:0001193125-26-104111:0
15,570 shares@ US$3.814.7% of flowClass A Common StockSEC:0001193125-26-071503:0
133,333 shares0Class A Common StockSEC:0000950170-25-019235:0
48,224 shares0Class A Common StockSEC:0000950170-25-007852:0
16,128 shares@ US$6.458.1% of flowClass A Common StockSEC:0000950170-24-063481:0
34,936 shares0Class A Common StockSEC:0000950170-24-029906:0
38,618 shares@ US$15.2445.9% of flowClass A Common StockSEC:0000950170-24-015557:0
57,971 shares0Class A Common StockSEC:0001209191-24-001905:0
10,324 shares@ US$10.128.1% of flowClass A Common StockSEC:0001209191-23-031874:0
69,869 shares0Class A Common StockSEC:0001209191-23-017889:0
7,146 shares@ US$11.416.5% of flowClass A Common StockSEC:0001209191-23-014280:0
14,663 shares0Class A Common StockSEC:0001209191-23-003999:0
3,130 shares@ US$11.500.0057% mcap9.1% of flowClass A Common StockSEC:0001209191-22-031842:0
81,448 shares0Class A Common StockSEC:0001209191-22-016184:0
1,367 shares@ US$10.771.2% of flowClass A Common StockSEC:0001209191-22-014652:0
29,326 shares0Class A Common StockSEC:0001104659-22-006551:0
13,776 shares@ US$11.5813.2% of flowClass A Common StockSEC:0001209191-21-066780:0
2,077 shares@ US$12.251.9% of flowClass A Common StockSEC:0001209191-21-035905:0
18 of 18 declarations
